EUVIMEDEUVIMED entdecken
Fall-Kontroll-Studie

Mir 143 rs353293 G>A Polymorphism is Not Associated with the Risk of Thyroid Cancer in the Iranian Population: A Case-Control Study

Nima Montazeri-Najafabady, Mohammad Hossein Dabbaghmanesh, Nazanin Chatrabnous, Mohammad Reza Arabnezhad, Rajeeh Mohammadian Amiri

Iranian Journal of Blood and Cancer · 2022

DOI: 10.58209/ijbc.14.1.6 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift Iranian Journal of Blood and Cancer, 2022. Verfasst von Nima Montazeri-Najafabady und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Montazeri-Najafabady, N., Dabbaghmanesh, M. H., Chatrabnous, N., Arabnezhad, M. R., & Amiri, R. M. (2022). Mir 143 rs353293 G>A Polymorphism is Not Associated with the Risk of Thyroid Cancer in the Iranian Population: A Case-Control Study. Iranian Journal of Blood and Cancer. https://doi.org/10.58209/ijbc.14.1.6

Vancouver

Montazeri-Najafabady N, Dabbaghmanesh MH, Chatrabnous N, Arabnezhad MR, Amiri RM. Mir 143 rs353293 G>A Polymorphism is Not Associated with the Risk of Thyroid Cancer in the Iranian Population: A Case-Control Study. Iranian Journal of Blood and Cancer. 2022. doi:10.58209/ijbc.14.1.6

BibTeX
@article{MontazeriNajafabady2022,
  author = {Montazeri-Najafabady, Nima and Dabbaghmanesh, Mohammad Hossein and Chatrabnous, Nazanin and Arabnezhad, Mohammad Reza and Amiri, Rajeeh Mohammadian},
  title = {Mir 143 rs353293 G>A Polymorphism is Not Associated with the Risk of Thyroid Cancer in the Iranian Population: A Case-Control Study},
  journal = {Iranian Journal of Blood and Cancer},
  year = {2022},
  doi = {10.58209/ijbc.14.1.6}
}
Kostenlos starten →